10x Genomics EBIT 2018-2025 | TXG

10x Genomics ebit from 2018 to 2025. Ebit can be defined as earnings before interest and taxes.

10x Genomics EBIT 2018-2025 | TXG

10x Genomics ebit from 2018 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$45.1B
Doximity (DOCS)$11.3B
Hims & Hers Health (HIMS)$10.7B
Tempus AI (TEM)$9.8B
IRhythm Technologies (IRTC)$4.3B
Inspire Medical Systems (INSP)$3.8B
Hinge Health (HNGE)$3.7B
Privia Health (PRVA)$2.5B
Enovis (ENOV)$1.9B
Phreesia (PHR)$1.6B
Schrodinger (SDGR)$1.5B
Azenta (AZTA)$1.5B
Clover Health Investments (CLOV)$1.5B
Omnicell (OMCL)$1.3B
Evolent Health (EVH)$1.3B
Claritev (CTEV)$761M
Fulgent Genetics (FLGT)$587M
Veradigm (MDRX)$547M
Standard BioTools (LAB)$501M
Butterfly Network (BFLY)$448M
Talkspace (TALK)$442M
Outset Medical (OM)$344M
TruBridge (TBRG)$331M
Health Catalyst (HCAT)$271M
Nyxoah SA (NYXH)$258M
SOPHiA GENETICS SA (SOPH)$233M
CapsoVision (CV)$212M
KORU Medical Systems (KRMD)$161M
Zepp Health (ZEPP)$150M
American Well (AMWL)$131M